LEON appoints Dr. Hans Frickel as Chief Executive Officer
leon-nanodrugs GmbH, announced the appointment of Dr. Hans Frickel as CEO, effective July 1, 2023.
Dr. Hans Frickel, a trained pharmacist and industrial manager, brings more than 20 years of experience in strategic and operational leadership roles across the entire value chain of pharmaceuticals and medical devices.
About LEON
LEON offers leading Technology for the encapsulation of nucleic acids, biomolecules, and other APIs.
Highly flexible GMP manufacturing solutions for your genetic payloads and other molecules.
LEON utilises its’ proprietary nano technology platform for the continuous manufacturing of SMART nanoparticles (ranging from surface stablilised polymeric through to lipid nanoparticles (LNP’s) and liposomes). For general information and enquiries please email info@leon-nanodrugs.com